Hosted by East Midlands Branch
This event will cover the role of dietitians in supporting people with incretin-based therapies, a case study illustrating the use of GLP-1s in young adults, and an individual perspective of what is it like to be on, and come off, GLP-1s.
There will be a short time for discussion and Q&A, followed by a brief AGM.
BDA's new evidence-based resource for eating well while taking medicines for obesity. These are offered free of charge to the public and healthcare professionals, and developed by the BDA Obesity Specialist Group. The resources have been developed through a process involving people living with obesity who take medications for obesity, dietitians and other healthcare professionals. Find out more and download your free guide
Novo Nordisk provided a grant and Eli Lilly and Company Limited provided sponsorship to the BDA to support costs of the development and production of this obesity management resource material. Novo Nordisk and Eli Lilly and Company have had no input into or influence over the creation, development or content contained in this material.
Admin Code Branch
